138 related articles for article (PubMed ID: 30014095)
1. Review: More-intensive vs less-intensive LDL-cholesterol lowering reduces mortality.
Yeboah J
Ann Intern Med; 2018 Jul; 169(2):JC6. PubMed ID: 30014095
[No Abstract] [Full Text] [Related]
2. Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering: A Systematic Review and Meta-analysis.
Navarese EP; Robinson JG; Kowalewski M; Kolodziejczak M; Andreotti F; Bliden K; Tantry U; Kubica J; Raggi P; Gurbel PA
JAMA; 2018 Apr; 319(15):1566-1579. PubMed ID: 29677301
[TBL] [Abstract][Full Text] [Related]
3. Is intensive LDL-cholesterol lowering beneficial and safe?
Cheung BM; Lam KS
Lancet; 2010 Nov; 376(9753):1622-4. PubMed ID: 21067806
[No Abstract] [Full Text] [Related]
4. Low-density lipoprotein cholesterol: how low can we go?
Sherbet DP; Garg P; Brilakis ES; Banerjee S
Am J Cardiovasc Drugs; 2013 Aug; 13(4):225-32. PubMed ID: 23609530
[TBL] [Abstract][Full Text] [Related]
5. Pooled RCTs: Lowering LDL-C levels using statins reduces major vascular events in all age groups.
Lee J; Holbrook A
Ann Intern Med; 2019 Jun; 170(12):JC65. PubMed ID: 31207618
[No Abstract] [Full Text] [Related]
6. [Strengthened support for statin therapy as secondary prevention. Doubtful evidence for more intensive lowering of cholesterol levels].
Håkansson J
Lakartidningen; 2011 Jun 1-14; 108(22-23):1234-5. PubMed ID: 21786497
[No Abstract] [Full Text] [Related]
7. Lowering LDL cholesterol is good, but how and in whom?
Stone NJ; Lloyd-Jones DM
N Engl J Med; 2015 Apr; 372(16):1564-5. PubMed ID: 25773740
[No Abstract] [Full Text] [Related]
8. Further LDL Lowering Could Reduce Cardiovascular Risk.
Mechcatie E; Rosenberg K
Am J Nurs; 2018 Nov; 118(11):55-56. PubMed ID: 30358599
[TBL] [Abstract][Full Text] [Related]
9. Statins and the cholesterol mortality paradox.
Nunes JP
Scott Med J; 2017 Feb; 62(1):19-23. PubMed ID: 27889702
[TBL] [Abstract][Full Text] [Related]
10. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
Gotto AM
N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15309745
[No Abstract] [Full Text] [Related]
11. High HDL may not protect the heart. Concentrate on lowering LDL for now, experts advise.
Harv Heart Lett; 2012 Sep; 23(1):6. PubMed ID: 23097807
[No Abstract] [Full Text] [Related]
12. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
Miller M
N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15309746
[No Abstract] [Full Text] [Related]
13. New therapies for reducing low-density lipoprotein cholesterol.
Stein EA; Raal FJ
Endocrinol Metab Clin North Am; 2014 Dec; 43(4):1007-33. PubMed ID: 25432394
[TBL] [Abstract][Full Text] [Related]
14. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
Pedersen TR
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
[TBL] [Abstract][Full Text] [Related]
15. Among statin-treated patients, LDL, non-HDL and apoB cholesterol biomarkers were associated with increased risks of cardiovascular events.
Sniderman AD; Thanassoulis G
Evid Based Med; 2013 Apr; 18(2):73-4. PubMed ID: 22893654
[No Abstract] [Full Text] [Related]
16. Lipid management for the prevention of cardiovascular disease.
Schaefer JR
Curr Pharm Des; 2011; 17(9):852-60. PubMed ID: 21418030
[TBL] [Abstract][Full Text] [Related]
17. [Considerable LDL lowering is advantageous].
MMW Fortschr Med; 2005 Sep; 147(35-36):9. PubMed ID: 16180563
[No Abstract] [Full Text] [Related]
18. [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly].
MMW Fortschr Med; 2005 Aug; 147(33-34):50-1. PubMed ID: 16138640
[No Abstract] [Full Text] [Related]
19. Lipid parameters and cardiovascular events in patients taking statins.
Brook RD; Rubenfire M
JAMA; 2012 Jul; 308(2):132; author reply 132-3. PubMed ID: 22782403
[No Abstract] [Full Text] [Related]
20. Lipid parameters and cardiovascular events in patients taking statins.
Martin SS; Jones SR
JAMA; 2012 Jul; 308(2):131-2; author reply 132-3. PubMed ID: 22782402
[No Abstract] [Full Text] [Related]
[Next] [New Search]
